Single-use Bioprocessing Market Overview:

The Global Single-use Bioprocessing (Sub) Market was valued at $2,800 million in 2016, and is expected to reach $9,342 million by 2023, registering a CAGR of 18.7% from 2017 to 2023. Single-use bioprocessing employs disposable technologies for the development and manufacturing of pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalized medicine, and others. The adoption of single-use bioprocessing products has witnessed significant increased during the developmental stages of drugs and manufacturing of several biopharmaceuticals. This product has revolutionized the upstream as well as downstream processes of manufacturing drugs making it faster, simpler, and cheaper. Factors that boost the growth of single-use bioprocessing market include increase in demand for biopharmaceuticals, rise in adoption of disposable technologies, low risk of product cross-contamination attributed to SUB technologies, and less floor space requirement. However, certain aspects such as, extractability and leachability issues and stringent regulations pertaining to use of disposable systems in biopharmaceutical industry hamper the market growth.

The single-use bioprocessing market is segmented based on product, method, application, end user, and region. Based on product, it is classified into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. Based on application, it is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. On the basis of method, it is categorized into filtration, storage, cell culture, mixing, and purification. Based on end user, it is classified into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers.

The media bags & containers segment dominated the global single-use bioprocessing market in 2016, and is anticipated maintain this trend throughout the forecast period. This is attributed to the fact that single-use bioprocessing media bags & containers are used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the biomanufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb); hence, this segment has a leading share in the global single-use bioprocessing market.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to overshadow that of the restraints. Moreover, increase in focus toward mergers, acquisitions, and product launches offer lucrative opportunities for the expansion of the global single-use bioprocessing market.

Request for Table of Content

Single-use bioprocessing technology incorporates several disposable products for the development of several pharmaceuticals products, such as vaccines, monoclonal antibodies, biologics, and others. The use of single-use products in the bioprocessing of drugs has increased over the recent years to cater to the demand for biopharmaceuticals globally. This technology offers several advantages over conventional bioprocessing methods such as increase in cost-effectiveness of the process, rise in productivity and flexibility, and improvement in the workflow. Single use bioprocessing products are widely used in relatively short span, owing to the remarkable features such as scalable implementation to both downstream and upstream operations in biopharmaceutical production and simplified design for rapid response. The other factors supplementing the market growth include faster installation of single-use products, lower water usage, lesser floor space requirement, and lower risk of product cross-contamination.

Single-use bioprocessing products use several disposable products such as bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, and mixing systems for upstream as well as downstream processing. The media bags and containers segment dominate the global single-use bioprocessing market, owing to its extensive use in transportation and storage of components essential for bioprocessing. In addition, biopharmaceutical manufacturers are the key end user of single-use bioprocessing technology. Furthermore, biopharmaceutical manufacturers use single-use technologies for manufacturing disposable products, owing to their feasibility and low cost of bioprocessing.

Single-use bioprocessing products are extensively used for manufacture monoclonal antibody production (mAbs) and vaccines. Monoclonal antibodies have immense potential in the treatment of cancer and autoimmune diseases. This have fueled the demand for monoclonal antibodies, which are produced by single-use technologies. Single use technologies have revolutionized the biomanufacturing sector for producing drugs in small amount for preclinical and clinical testing. Nevertheless, these technologies are used through all stages of the bioproduction workflow, right from initial buffer and media preparation in bioreactor to the cultures prepared for vaccines along with the end work storage, and shipping of intermediates as well as bulk biologics. Therefore, the single use technologies have progressed rapidly over the past few years, resulting in increased focus toward continuous bioprocessing by implementing single use systems. This has created lucrative opportunities for leading manufacturers operating in the global single-use bioprocessing market to expand their market presence.